Biostatistics PhD Student @ MRC Biostatistics Unit @ University of Cambridge

Joined November 2018
4 Photos and videos
Pinned Tweet
18 Jan 2025
I have moved to Bluesky! Tried to find as many of you as I could, but if I could not find you please add me: lukaspin.bsky.social #ByeX #ResearchersLeavingX #NoSupportForMusk

48
Lukas Pin retweeted
Freshly available to read. How to know if approximating probabilities in a Bayesian RA(r) design is good enough? Exact calculations for binary endpoints allow us to suggest a benchmarking procedure that takes speed and accuracy into account. πŸ“’ @MRC_BSU arxiv.org/pdf/2411.19871

5
11
744
Lukas Pin retweeted
Today, our wonderful cohort of #PhD students are running a symposium, with fantastic talks and poster presentations from them each of them πŸ€©πŸ˜πŸ‘ @Cambridge_Uni @The_MRC
1
2
20
1,056
Lukas Pin retweeted
A great day today. Chris gave a wonderful accessible and challenging lecture walking us through sequential clinical trials. Dinner was well earned! 😊
3
20
702
Lukas Pin retweeted
7 Oct 2024
Preprint on a Mapping strategy introduced in a Response Adaptive Randomised trial of a rare disease, which discretises randomisation probabilities to target allocation ratios, avoiding undesirable outcomes… arxiv.org/abs/2410.03346 @DeliuNina @mark_toshner @SofiaSVillar1
2
6
13
1,121
Lukas Pin retweeted
Congrats to BSU Programme Leader, @SofiaSVillar1, on being nominated for @Cambridge_Uni Research Culture Celebration 2024, for her contributions to creating a positive research culture πŸŽŠπŸ‘πŸ€© Read more πŸ‘‡ mrc-bsu.cam.ac.uk/news/resea…
2
3
16
2,197
Lukas Pin retweeted
Wonderful closing of the short course! Super motivated by the audience's questions. Thanks to all contributing to this two days πŸ™ @MRC_BSU @PinLukas96 @ra
3
13
669
Lukas Pin retweeted
Lectures and infusion of choice for the response adaptive design course today at @MRC_BSU super engaged audience today πŸ™‚
2
13
645
Lukas Pin retweeted
Great presentations, discussions and networking for members of our Efficient Study Design theme at #ICTMC2024 πŸ˜€πŸ€©
3
16
911
Lukas Pin retweeted
Well done to @rajenki, @PinLukas96, Nikita Mozgunov and Stef Baas (@SofiaSVillar1 standing in for Stef) on their brilliant poster presentations at #ICTMC2024 πŸ€©πŸ‘
3
5
20
1,096
Come by my poster β€žImplementing and Assessing Bayesian Response-Adaptive-Randomisation for Backfilling in Dose-Finding Trailsβ€œ at #ICTMC2024 from 12:10-12:30 TODAY. Looking forward to seeing everyone 🏴󠁧󠁒󠁳󠁣󠁴󠁿 #AdaptiveDesigns #RAR #Oncology @SofiaSVillar1 @HakDehbi @MRC_BSU
1
12
572
Lukas Pin retweeted
The researchers and students in our fantastic Efficient Study Design theme had a great away day on Friday which ended with fun and games πŸ˜€ @SofiaSVillar1 @thomas_jaki @pmozgunov @mlawofaverages @MiaTackney @rajenki @Xijin_Chen @PinLukas96 @AleSerra05
1
14
1,212
Lukas Pin retweeted
Our latest video interview is with #PhD student @PinLukas96. Lukas talks about why he enjoys doing a PhD at the BSU and what has surprised him so far. youtu.be/kWY0jFBVdVI @Cambridge_Uni @Cam_Grads
1
5
400
Lukas Pin retweeted
Reflecting back on a great Away Day last week πŸ˜€ So many engaging talks and group activities, all on the theme of research culture. Looking forward to what is to come for our brilliant and dynamic Unit.
5
24
1,827
πŸš€ New paper alert! πŸš€ Exciting new results on "Implementing and assessing Bayesian response-adaptive randomisation for backfilling in dose-finding trials" by @PinLukas96 , @SofiaSVillar1 and @HakDehbi. πŸ“ŠπŸ§¬ Check out the full paper here: doi.org/10.1016/j.cct.2024.1… (1/14)
13
3
14
2,852
Has anyone else ever been in the same room with all their co-authors when their paper got accepted? πŸŒŸπŸ“Š #Academia #ClinicalTrials #Research (14/14)
2
95
πŸ–ΌοΈ Funny coincidence! Just as @HakDehbi , @SofiaSVillar1 , and I were sitting together in the same row at 1st Contemporary Clinical Trials Methodology Meeting hosted by @ImperialCTU , we received the exciting news that our paper passed the revision process! #Randomness (13/14)
4
556
πŸ” In summary, BRAR offers a patient-oriented approach to backfilling, enhancing dose-finding trials. We're excited to continue developing statistical methods for modern clinical trials. Stay tuned for more! πŸ“ˆπŸŒŸ#ClinicalInnovation #FutureDirections (12/14)
64
🌐 BRAR and backfilling methodologies extend beyond oncology, applicable to other fields like neonatology. We encourage exploring these innovative methods in diverse settings. πŸŒŸπŸ“Š #InnovativeResearch #BeyondOncology (11/14)
48
πŸ”¬ Future research directions include exploring continuous efficacy markers, like tumor biomarkers, for better dose-efficacy understanding or flexible backfill cohort sizes. πŸ§¬πŸ”¬ #FutureResearch (10/14)
56